What is he best known for?
The fields of study he is best known for:
Dieter Marmé mainly investigates Vascular endothelial growth factor, Angiogenesis, Vascular endothelial growth factor A, Cancer research and Molecular biology.
His Vascular endothelial growth factor study combines topics from a wide range of disciplines, such as Endocrinology, Metastasis and Growth factor.
His Angiogenesis research incorporates elements of Tumor progression, Immunology and Pathology.
As part of one scientific family, Dieter Marmé deals mainly with the area of Vascular endothelial growth factor A, narrowing it down to issues related to the Cell biology, and often Transfection, Platelet-derived growth factor receptor, 3T3 cells and Promoter.
His Cancer research research integrates issues from Tumor suppressor gene, Transcription factor and Receptor tyrosine kinase.
His Molecular biology research includes elements of Receptor, Protein kinase C, MAP kinase kinase kinase, c-Raf and ASK1.
His most cited work include:
- Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. (1496 citations)
- Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 (1227 citations)
- Protein kinase Cα activates RAF-1 by direct phosphorylation (1172 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Biochemistry, Vascular endothelial growth factor, Angiogenesis, Molecular biology and Calmodulin.
His Calcium research extends to Biochemistry, which is thematically connected.
The study incorporates disciplines such as Endocrinology and Growth factor in addition to Vascular endothelial growth factor.
The Angiogenesis study combines topics in areas such as Receptor tyrosine kinase, Metastasis and Pathology.
His study explores the link between Molecular biology and topics such as MAP2K7 that cross with problems in Cyclin-dependent kinase 9, Mitogen-activated protein kinase kinase and MAP kinase kinase kinase.
His work focuses on many connections between Vascular endothelial growth factor A and other disciplines, such as Endothelial stem cell, that overlap with his field of interest in Chorioallantoic membrane.
He most often published in these fields:
- Biochemistry (33.99%)
- Vascular endothelial growth factor (25.49%)
- Angiogenesis (21.57%)
What were the highlights of his more recent work (between 1999-2020)?
- Angiogenesis (21.57%)
- Vascular endothelial growth factor (25.49%)
- Internal medicine (16.34%)
In recent papers he was focusing on the following fields of study:
Dieter Marmé mainly investigates Angiogenesis, Vascular endothelial growth factor, Internal medicine, Pathology and Endocrinology.
His research integrates issues of Endothelial stem cell, Receptor tyrosine kinase and Cell biology in his study of Angiogenesis.
The various areas that Dieter Marmé examines in his Vascular endothelial growth factor study include Immunology, Angiogenesis inhibitor, Metastasis, Ischemia and Pharmacology.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Surgery and Cardiology.
His Pathology study incorporates themes from Primary tumor and Melanoma.
His Apoptosis course of study focuses on Cytotoxic T cell and Molecular biology.
Between 1999 and 2020, his most popular works were:
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I Studies (625 citations)
- Effects of PTK787/ZK 222584, a Specific Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, on Primary Tumor, Metastasis, Vessel Density, and Blood Flow in a Murine Renal Cell Carcinoma Model (300 citations)
- Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. (219 citations)
In his most recent research, the most cited papers focused on:
Dieter Marmé spends much of his time researching Angiogenesis, Vascular endothelial growth factor, Pathology, Cancer research and Receptor tyrosine kinase.
He is interested in Neovascularization, which is a field of Angiogenesis.
In his study, Vatalanib is inextricably linked to Metastasis, which falls within the broad field of Vascular endothelial growth factor.
Dieter Marmé combines subjects such as Primary tumor, Melanoma, Transfection and Ephrin with his study of Pathology.
His Cancer research research incorporates themes from In vitro, Cell growth, Molecular biology, Curcumin and Endothelium.
His Receptor tyrosine kinase study combines topics in areas such as Enzyme-linked receptor, Angiogenesis inhibitor, Growth factor receptor and TIE1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
